(702) 505-4230


Current Research – Actively Enrolling

Current Research – Enrollment Closed

Alexion Pharmaceuticals – ALXN1210-MG-306

A Phase 3, Randomized, Placebo Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Ravulizumab in Complement-Inhibitor-Naïve Adult Patients with Generalized Myasthenia Gravis

Mitsubishi Tanabe Pharma America – MT-1186-A02

A Phase 3b, Multicenter, Randomized, Double-Blind Study to Evaluate Efficacy and Safety of Oral Edaravone Administered for a Period of 48 Weeks in Subjects with Amyotrophic Lateral Sclerosis (ALS)

Mitsubishi Tanabe Pharma America – REFINE-ALS

Radicava®/(Edaravone) Findings in Biomarkers From ALS

Muscular Dystrophy Association – MDACS1

Neuromuscular Observational Research (MOVR) Data Hub

Sarepta Therapeutics – SRP4658-403

A Long-Term Observational Study Evaluating Sarepta Therapeutics, Inc.’s Exon-Skipping Therapies in Patients with Duchenne Muscular Dystrophy under Conditions of Routine Clinical Practice

For more information on our current research projects, contact our Clinical Research department at research@lavegasclinic.org.

Our Mission

Las Vegas Clinic is a Center of Excellence for Neurology